U.S. markets closed

Pharming Group N.V. (PHAR)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
12.51-0.75 (-5.66%)
At close: 4:00PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Momentum

Momentum

Previous Close13.26
Open13.35
Bid13.01 x 4000
Ask14.21 x 1200
Day's Range12.51 - 13.20
52 Week Range12.23 - 21.99
Volume23
Avg. Volume7,475
Market Cap791.981M
Beta (5Y Monthly)1.76
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Undervalued
85% Est. Return
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
    View more
    • Pharming Group announces the filing of its 2020 Annual Report on Form 20-F with the U.S. Securities and Exchange Commission
      PR Newswire

      Pharming Group announces the filing of its 2020 Annual Report on Form 20-F with the U.S. Securities and Exchange Commission

      Pharming Group N.V. ("Pharming" or "the Company") (Euronext Amsterdam: PHARM/Nasdaq: PHAR) announces the filing of its Annual Report on Form 20-F for the year ended 31 December 2020 with the U.S. Securities and Exchange Commission (SEC), which is available on the Company's website www.pharming.com under Investors/SEC filings.

    • Pharming Group announces the publication of its 2020 Annual Report and convenes its 2021 AGM
      PR Newswire

      Pharming Group announces the publication of its 2020 Annual Report and convenes its 2021 AGM

      Pharming Group N.V. ("Pharming" or "the Company") (Euronext Amsterdam: PHARM/Nasdaq: PHAR) announces the publication of its Annual Report for the year ended 31 December 2020, which is available on the Company's website www.pharming.com under Investors/Financial Documents.

    • Pharming Group announces the intention to nominate three Non-Executive Directors to the Board of Directors
      PR Newswire

      Pharming Group announces the intention to nominate three Non-Executive Directors to the Board of Directors

      Pharming Group N.V. ("Pharming" or "the Company") (Euronext Amsterdam: PHARM) (Nasdaq: PHAR) announces the intention to nominate Steven Baert, Leon Kruimer and Jabine van der Meijs as Non-Executive Directors to the Board. Their official appointments will be confirmed by the Company's Annual General Meeting of Shareholders that will be held on 19 May 2021. Until that moment, Steven Baert, Leon Kruimer and Jabine van der Meijs will hold observational roles on the Board of Directors. Steven, Leon and Jabine will be replacing Juergen Ernst who stepped down in November 2020 and Aad de Winter and Barrie Ward, both of whom cannot be re-elected due to the maximum term of office for Non-Executive Directors according to the Dutch Corporate Governance Code.